<DOC>
	<DOCNO>NCT00098228</DOCNO>
	<brief_summary>The trial design identify appropriate dose QAB149 delivery via multiple dose inhaler use COPD Phase III program .</brief_summary>
	<brief_title>Dose-Ranging Study Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Diagnosis COPD Age 4075 year Smoking history Other serious disease Allergy QAB149 Respiratory tract infection</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>COPD , adult , QAB149</keyword>
</DOC>